CLS announces first glioblastoma patient treated with the MR-guided Laser Interstitial Thermal Therapy (MRg LITT) in the study at Skåne University Hospital
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS), which develops advanced innovative products for high-precision image guided laser ablation, today announced that the first patient has been safely treated in the clinical trial at Skåne University Hospital (SUS) aiming to evaluate MR-guided Laser Interstitial Thermal Therapy (MRg LITT) for glioblastoma ablation.The CLS sponsored study at Skåne University Hospital is a single-center, single-arm, prospective clinical trial, with the aim to evaluate safety and feasibility of